Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

TSUBASA Study: A Prospective Study Evaluating the Association between Physical Activity and Bleeding Events, Quality of Daily Life, and Safety in People with Hemophilia A without FVIII Inhibitors

Keiji Nogami, Teruhisa Fujii, Akihiro Sawada, Azusa Nagao, Chiai Nagae, Masanori Nojima, Nobuaki Suzuki, Mika Kawano, Tomomi Shimura, Yoshimasa Sugao, Kagehiro Amano

Blood (2024) 144 (Supplement 1): 1211.

https://doi.org/10.1182/blood-2024-193537

Published: 2024

Journal Articles

Differentiation of Acquired Hemophilia a from Lupus Anticoagulant Using Global Coagulation Assays and Magnesium-Dependent Activated Partial Thromboplastin Time Assay

Yushi Chikasawa, Kagehiro Amano, Keiko Shinozawa, Masato Bingo, Ryui Miyashita, Tomoko Yamaguchi, Akito Ichiki, Ryoko Sekiya, Takashi Muramatsu, Mihoko Yotsumoto, Ayano Mitsuhashi, Takeshi Hagiwara, Hiroshi Inaba, Ei Kinai

Blood (2023) 142 (Supplement 1): 5463.

https://doi.org/10.1182/blood-2023-179884

Published: 2023

Journal Articles

ORIHIME II Study: Background, Treatment Status, and Outcomes of Patients with Acquired Hemophilia A with Low Activities of Daily Living Scores or Undergoing Rehabilitation - a Japanese Health Claims Database Analysis

Yoshiyuki Ogawa, Kagehiro Amano, Akiko Ioka, Daisuke Nosaka, Yoichi Murakami, Hiroki Adachi, Keiji Nogami

Blood (2022) 140 (Supplement 1): 5627–5628.

https://doi.org/10.1182/blood-2022-157170

Published: 2022

Journal Articles

Orihime Study: Real World Treatment Patterns and Clinical Outcomes of 338 Patients with Acquired Hemophilia a from a Japanese Health Claims Database

Yoshiyuki Ogawa, Kagehiro Amano, Yukari Matsuo-Tezuka, Norihiro Okada, Yoichi Murakami, Takao Nakamura, Haruko Yamaguchi-Suita, Keiji Nogami

Blood (2021) 138 (Supplement 1): 1042.

https://doi.org/10.1182/blood-2021-146418

Published: 2021

Journal Articles

An Investigational Dosing Algorithm of Emicizumab for Prophylaxis in Acquired Hemophilia a

Midori Shima, MD, Sayaka Nagami, BSc, Koichiro Yoneyama, MSc, Akira Nomura, MSc, Yoshiyuki Ogawa, MD PhD, Kagehiro Amano, MD PhD, Keiji Nogami, MDPhD

Blood (2020) 136 (Supplement 1): 26–27.

https://doi.org/10.1182/blood-2020-136488

Published: 2020

Journal Articles

Molecular Diagnosis of Hemophilia B Leyden in Japanese Brothers Reveals Spontaneous Amelioration in Early Childhood with c. -35 G>A Onecut Binding Site Mutation

Akihiro Tamura, MD, Daiichiro Hasegawa, MD PhD, Sayaka Nakamura, MD, Takahiro Fujiwara, MD, Teppei Tahara, MD, Nobuyuki Yamamoto, MD PhD, Atsuro Saito, MD, Aiko Kozaki, MD, Kenji Kishimoto, MD, Toshiaki Ishida, MD PhD, Keiko Shinozawa, PhD, Kagehiro Amano, MD PhD, Katsuyuki Fukutake, MD PhD, Yoshiyuki Kosaka, MD, PhD

Blood (2017) 130 (Supplement 1): 3680.

https://doi.org/10.1182/blood.V130.Suppl_1.3680.3680

Published: 2017

Journal Articles

The Genetic Analysis of Hemophilia a: The Application of Next-Generation Sequencing in the Analysis of Causative Variants Deep inside the Intron of the F8 Gene

Hiroshi Inaba, PhD, Keiko Shinozawa, PhD, Kagehiro Amano, MD PhD, Katsuyuki Fukutake, MD PhD

Blood (2016) 128 (22): 1393.

https://doi.org/10.1182/blood.V128.22.1393.1393

Published: 2016

Journal Articles

Outcome of the Japanese Immune Tolerance Induction (ITI) Registry and Predictors of Successful ITI

Keiji Nogami, MD PhD, Masashi Taki, MD PhD, Tadashi Matsushita, MD PhD, Shouichi Ohga, MD PhD, Hideji Hanabusa, Toshiaki Oka, MD, Yasuo Horikoshi, MD, Kagehiro Amano, MD PhD, Midori Shima, MD PhD

Blood (2015) 126 (23): 3526.

https://doi.org/10.1182/blood.V126.23.3526.3526

Published: 2015

Journal Articles

Novel FV mutation (W1920R, FV Nara ) associated with serious deep vein thrombosis and more potent APC resistance relative to FV Leiden

Keiji Nogami, Keiko Shinozawa, Kenichi Ogiwara, Tomoko Matsumoto, Kagehiro Amano, Katsuyuki Fukutake, Midori Shima

Blood (2014) 123 (15): 2420–2428.

https://doi.org/10.1182/blood-2013-10-530089

Published: 2014

Journal Articles

Evaluation of the Safety, Efficacy of Recombinant Factor IX (nonacog alfa) in Japanese Patients with Hemophilia B- Interim Result of Post Marketing Surveillance Study -

Takashi Suzuki, MD, PhD, Katsuyuki Fukutake, MD, PhD, Kagehiro Amano, MD, PhD, Hideji Hanabusa, MD, Masashi Taki, MD, PhD, Tadashi Matsushita, MD, PhD, Midori Shima, MD, PhD, Michio Sakai, MD, PhD, Masahiro Iizuka, Yoshiyuki Shibasaki

Blood (2012) 120 (21): 3378.

https://doi.org/10.1182/blood.V120.21.3378.3378

Published: 2012

Journal Articles

Severe Factor V Deficiency Caused by a Novel Compound Heterozygous Mutation: Factor V G1617V and 1-Bp Insertion

Keiko Shinozawa, PhD, Yuri Okimoto, MD, PhD, Kagehiro Amano, MD, PhD, Harumi Kakuda, MD, PhD, Takeshi Hagiwara, MD, PhD, Takashi Suzuki, MD, PhD, Hiroshi Inaba, PhD, Katsuyuki Fukutake, MD, PhD

Blood (2011) 118 (21): 2268.

https://doi.org/10.1182/blood.V118.21.2268.2268

Published: 2011

Journal Articles

The Etiology of Hemophilia Hiding Deep Inside the F8 Intronic Sequence

Hiroshi Inaba, PhD, Keiko Shinozawa, PhD, Takeshi Hagiwara, MD, PhD, Kagehiro Amano, MD, PhD, Katsuyuki Fukutake, MD, PhD

Blood (2011) 118 (21): 1223.

https://doi.org/10.1182/blood.V118.21.1223.1223

Published: 2011

Journal Articles

Identification and Characterization of L1-Mediated Large Tandem Duplication, Spanning Exon 4 to 10 of the F13A1 , In a Patient with Congenital Factor XIII Deficiency.

Hiroshi Inaba, PhD, Keiko Shinozawa, PhD, Kagehiro Amano, MD, PhD, Katsuyuki Fukutake, MD, PhD

Blood (2010) 116 (21): 3659.

https://doi.org/10.1182/blood.V116.21.3659.3659

Published: 2010

Journal Articles

The Severity of Bleeding Tendency in 5 Patients with Factor V Deficiency Due to Distinct Kinds of Factor V Mutations.

Keiko Shinozawa, PhD, Kagehiro Amano, MD, PhD, Takashi Suzuki, MD, PhD, Hiroshi Inaba, PhD, Katsuyuki Fukutake, MD, PhD

Blood (2007) 110 (11): 1764.

https://doi.org/10.1182/blood.V110.11.1764.1764

Published: 2007

Journal Articles

The Molecular Basis for Cross-Reacting Material–Positive Hemophilia A Due to Missense Mutations Within the A2-Domain of Factor VIII

Kagehiro Amano, Rita Sarkar, Susan Pemberton, Geoffrey Kemball-Cook, Haig H. Kazazian, Jr, Randal J. Kaufman

Blood (1998) 91 (2): 538–548.

https://doi.org/10.1182/blood.V91.2.538

Published: 1998

NARROW

TSUBASA Study: A Prospective Study Evaluating the Association between Physical Activity and Bleeding Events, Quality of Daily Life, and Safety in People with Hemophilia A without FVIII Inhibitors

Differentiation of Acquired Hemophilia a from Lupus Anticoagulant Using Global Coagulation Assays and Magnesium-Dependent Activated Partial Thromboplastin Time Assay

ORIHIME II Study: Background, Treatment Status, and Outcomes of Patients with Acquired Hemophilia A with Low Activities of Daily Living Scores or Undergoing Rehabilitation - a Japanese Health Claims Database Analysis

Orihime Study: Real World Treatment Patterns and Clinical Outcomes of 338 Patients with Acquired Hemophilia a from a Japanese Health Claims Database

An Investigational Dosing Algorithm of Emicizumab for Prophylaxis in Acquired Hemophilia a

Molecular Diagnosis of Hemophilia B Leyden in Japanese Brothers Reveals Spontaneous Amelioration in Early Childhood with c. -35 G>A Onecut Binding Site Mutation

The Genetic Analysis of Hemophilia a: The Application of Next-Generation Sequencing in the Analysis of Causative Variants Deep inside the Intron of the F8 Gene

Outcome of the Japanese Immune Tolerance Induction (ITI) Registry and Predictors of Successful ITI

Novel FV mutation (W1920R, FV Nara ) associated with serious deep vein thrombosis and more potent APC resistance relative to FV Leiden

Evaluation of the Safety, Efficacy of Recombinant Factor IX (nonacog alfa) in Japanese Patients with Hemophilia B- Interim Result of Post Marketing Surveillance Study -

Severe Factor V Deficiency Caused by a Novel Compound Heterozygous Mutation: Factor V G1617V and 1-Bp Insertion

The Etiology of Hemophilia Hiding Deep Inside the F8 Intronic Sequence

Identification and Characterization of L1-Mediated Large Tandem Duplication, Spanning Exon 4 to 10 of the F13A1 , In a Patient with Congenital Factor XIII Deficiency.

The Severity of Bleeding Tendency in 5 Patients with Factor V Deficiency Due to Distinct Kinds of Factor V Mutations.

The Molecular Basis for Cross-Reacting Material–Positive Hemophilia A Due to Missense Mutations Within the A2-Domain of Factor VIII

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only